Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$47.78
-0.2%
$48.92
$45.56
$58.19
$193.47B0.8719.26 million shs11.60 million shs
International Business Machines Co. stock logo
IBM
International Business Machines
$167.51
+0.2%
$187.19
$120.55
$199.18
$153.56B0.75.01 million shs5.26 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.84
+0.5%
$155.07
$143.13
$175.97
$353.85B0.537.36 million shs6.46 million shs
Microsoft Co. stock logo
MSFT
Microsoft
$402.25
-1.0%
$414.45
$303.40
$430.82
$2.99T0.8922.09 million shs19.57 million shs
Pfizer Inc. stock logo
PFE
Pfizer
$25.65
+1.0%
$26.92
$25.20
$40.37
$145.24B0.6142.00 million shs41.63 million shs
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
-0.17%-0.75%-4.27%-8.54%+1.12%
International Business Machines Co. stock logo
IBM
International Business Machines
+0.23%-7.93%-12.28%-10.82%+32.51%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+0.48%-1.53%-7.17%-7.51%-10.30%
Microsoft Co. stock logo
MSFT
Microsoft
-1.00%+0.32%-4.39%-1.55%+30.92%
Pfizer Inc. stock logo
PFE
Pfizer
+0.98%-2.32%-7.57%-5.07%-34.04%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
4.6707 of 5 stars
3.13.04.23.61.92.51.3
International Business Machines Co. stock logo
IBM
International Business Machines
4.1998 of 5 stars
2.13.04.23.51.80.81.9
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9353 of 5 stars
3.23.04.23.93.82.51.9
Microsoft Co. stock logo
MSFT
Microsoft
4.8897 of 5 stars
3.53.03.32.92.62.52.5
Pfizer Inc. stock logo
PFE
Pfizer
4.9784 of 5 stars
3.23.04.24.83.01.73.1

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
2.19
Hold$55.5316.22% Upside
International Business Machines Co. stock logo
IBM
International Business Machines
2.23
Hold$184.089.89% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8619.76% Upside
Microsoft Co. stock logo
MSFT
Microsoft
2.94
Moderate Buy$452.6112.52% Upside
Pfizer Inc. stock logo
PFE
Pfizer
2.38
Hold$36.3341.65% Upside

Current Analyst Ratings

Latest JNJ, IBM, MSFT, CSCO, and PFE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/26/2024
International Business Machines Co. stock logo
IBM
International Business Machines
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$186.00 ➝ $179.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$480.00 ➝ $500.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$450.00 ➝ $480.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Wedbush
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$500.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$455.00 ➝ $465.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$465.00 ➝ $489.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$440.00 ➝ $470.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$475.00 ➝ $485.00
4/26/2024
Microsoft Co. stock logo
MSFT
Microsoft
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$450.00 ➝ $515.00
4/25/2024
International Business Machines Co. stock logo
IBM
International Business Machines
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$190.00 ➝ $185.00
4/25/2024
International Business Machines Co. stock logo
IBM
International Business Machines
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Perform ➝ Market Perform$210.00 ➝ $190.00
(Data available from 4/30/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$57.00B3.39$3.87 per share12.36$10.88 per share4.39
International Business Machines Co. stock logo
IBM
International Business Machines
$62.07B2.47$14.57 per share11.50$24.76 per share6.77
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.16$13.74 per share10.69$28.57 per share5.14
Microsoft Co. stock logo
MSFT
Microsoft
$211.92B14.11$11.62 per share34.63$27.76 per share14.49
Pfizer Inc. stock logo
PFE
Pfizer
$58.50B2.48$3.01 per share8.53$15.81 per share1.62

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$12.61B$3.2914.5215.412.7623.49%33.01%14.72%5/15/2024 (Confirmed)
International Business Machines Co. stock logo
IBM
International Business Machines
$7.50B$8.8318.9715.954.0813.18%40.21%6.88%7/17/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1513.432.4145.26%36.43%15.01%7/18/2024 (Estimated)
Microsoft Co. stock logo
MSFT
Microsoft
$72.36B$11.5534.8330.432.1836.43%37.54%19.02%7/23/2024 (Estimated)
Pfizer Inc. stock logo
PFE
Pfizer
$2.12B$0.3671.259.261.143.62%10.88%4.91%5/1/2024 (Confirmed)

Latest JNJ, IBM, MSFT, CSCO, and PFE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2024N/A
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$0.71N/A-$0.71N/AN/AN/A  
5/1/2024N/A
Pfizer Inc. stock logo
PFE
Pfizer
$0.57N/A-$0.57N/AN/AN/A  
4/30/2024Q1 24
International Business Machines Co. stock logo
IBM
International Business Machines
$1.59$1.68+$0.09$1.64$14.53 billion$14.46 billion    
4/25/2024Q3 2024
Microsoft Co. stock logo
MSFT
Microsoft
$2.81$2.94+$0.13$2.94$60.86 billion$61.86 billion    
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
2/14/2024Q2 24
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$0.84$0.87+$0.03$0.79$12.71 billion$12.79 billion      
1/30/2024Q2 24
Microsoft Co. stock logo
MSFT
Microsoft
$2.76$2.93+$0.17$2.93$61.14 billion$62.02 billion    
1/30/202412/31/2023
Pfizer Inc. stock logo
PFE
Pfizer
-$0.19$0.10+$0.29$0.80$14.37 billion$14.25 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
$1.603.35%+2.72%48.63%13 Years
International Business Machines Co. stock logo
IBM
International Business Machines
$6.643.96%+0.61%75.20%28 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.24%+5.70%29.68%63 Years
Microsoft Co. stock logo
MSFT
Microsoft
$3.000.75%+10.11%25.97%22 Years
Pfizer Inc. stock logo
PFE
Pfizer
$1.686.55%+2.57%466.67%15 Years

Latest JNJ, IBM, MSFT, CSCO, and PFE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/24/2024
Pfizer Inc. stock logo
PFE
Pfizer
quarterly$0.426.4%5/9/20245/10/20246/14/2024
3/12/2024
Microsoft Co. stock logo
MSFT
Microsoft
quarterly$0.750.72%5/15/20245/16/20246/13/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
2/14/2024
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
quarterly$0.403.18%4/3/20244/4/20244/24/2024
1/30/2024
International Business Machines Co. stock logo
IBM
International Business Machines
quarterly$1.663.55%2/8/20242/9/20243/9/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
0.14
1.37
1.26
International Business Machines Co. stock logo
IBM
International Business Machines
2.32
1.13
1.09
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91
Microsoft Co. stock logo
MSFT
Microsoft
0.17
1.24
1.23
Pfizer Inc. stock logo
PFE
Pfizer
0.69
0.91
0.69

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
73.33%
International Business Machines Co. stock logo
IBM
International Business Machines
58.96%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%
Microsoft Co. stock logo
MSFT
Microsoft
71.13%
Pfizer Inc. stock logo
PFE
Pfizer
68.36%

Insider Ownership

CompanyInsider Ownership
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
0.02%
International Business Machines Co. stock logo
IBM
International Business Machines
0.07%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
Microsoft Co. stock logo
MSFT
Microsoft
0.03%
Pfizer Inc. stock logo
PFE
Pfizer
0.06%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Cisco Systems, Inc. stock logo
CSCO
Cisco Systems
84,9004.05 billion4.05 billionOptionable
International Business Machines Co. stock logo
IBM
International Business Machines
305,300916.75 million916.10 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable
Microsoft Co. stock logo
MSFT
Microsoft
221,0007.43 billion7.43 billionOptionable
Pfizer Inc. stock logo
PFE
Pfizer
88,0005.66 billion5.66 billionOptionable

JNJ, IBM, MSFT, CSCO, and PFE Headlines

SourceHeadline
Pfizer,Genmab: FDA Grants Full Approval For TIVDAK To Treat Recurrent Or Metastatic Cervical CancerPfizer,Genmab: FDA Grants Full Approval For TIVDAK To Treat Recurrent Or Metastatic Cervical Cancer
markets.businessinsider.com - April 29 at 11:47 PM
Van ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE)Van ECK Associates Corp Raises Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 29 at 8:49 PM
These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To ClimbThese 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their Share Prices To Climb
finance.yahoo.com - April 29 at 6:46 PM
UPDATE 1-US FDA grants full approval for Pfizers cervical cancer drugUPDATE 1-US FDA grants full approval for Pfizer's cervical cancer drug
finance.yahoo.com - April 29 at 6:46 PM
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
finance.yahoo.com - April 29 at 6:46 PM
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
finance.yahoo.com - April 29 at 6:46 PM
FDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer
businesswire.com - April 29 at 6:40 PM
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
businesswire.com - April 29 at 6:40 PM
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
globenewswire.com - April 29 at 6:40 PM
US FDA grants full approval for Pfizers cervical cancer drugUS FDA grants full approval for Pfizer's cervical cancer drug
reuters.com - April 29 at 4:09 PM
Pfizer (NYSE:PFE) Trading Up 1.3%Pfizer (NYSE:PFE) Trading Up 1.3%
marketbeat.com - April 29 at 3:17 PM
These Pharmaceutical Firms Are On Sale: Abbvie, Pfizer, And GileadThese Pharmaceutical Firms Are On Sale: Abbvie, Pfizer, And Gilead
msn.com - April 29 at 1:46 PM
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dosePfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose
bizjournals.com - April 29 at 1:46 PM
Heres How to Play Pfizer (PFE) Stock Ahead of Q1 EarningsHere's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
zacks.com - April 29 at 1:16 PM
Why Pfizer (PFE) is a Top Value Stock for the Long-TermWhy Pfizer (PFE) is a Top Value Stock for the Long-Term
zacks.com - April 29 at 10:46 AM
3 Ultra-Yield Dividend Stocks Retirees Can Trust3 Ultra-Yield Dividend Stocks Retirees Can Trust
247wallst.com - April 29 at 10:20 AM
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizers Newly Approved Gene Therapy to Treat Patients with Hemophilia BLabcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
prnewswire.com - April 29 at 7:09 AM
Pfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingPfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual Meeting
businesswire.com - April 29 at 6:45 AM
3 Dividend Stocks to Buy on the Dip: April 20243 Dividend Stocks to Buy on the Dip: April 2024
investorplace.com - April 29 at 6:00 AM
Raymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)Raymond James & Associates Raises Position in Pfizer Inc. (NYSE:PFE)
marketbeat.com - April 28 at 10:53 PM
The Motley Fool: Pfizer offers a pfat 6.4% dividendThe Motley Fool: Pfizer offers a pfat 6.4% dividend
dallasnews.com - April 28 at 2:54 PM
5 Of The Highest Yielding Blue Chip Stocks To Buy Now5 Of The Highest Yielding Blue Chip Stocks To Buy Now
247wallst.com - April 28 at 7:45 AM
3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street3 High-Yield Dividend Stocks That Could Soar 22% to 49%, According to Wall Street
fool.com - April 28 at 5:50 AM
Pfizer (NYSE:PFE) Stock Price Up 0.3%Pfizer (NYSE:PFE) Stock Price Up 0.3%
americanbankingnews.com - April 28 at 3:18 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Cisco Systems logo

Cisco Systems

NASDAQ:CSCO
Cisco Systems, Inc. designs, manufactures, and sells Internet Protocol based networking and other products related to the communications and information technology industry in the Americas, Europe, the Middle East, Africa, the Asia Pacific, Japan, and China. The company also offers switching portfolio encompasses campus switching as well as data center switching; enterprise routing portfolio interconnects public and private wireline and mobile networks, delivering highly secure, and reliable connectivity to campus, data center and branch networks; wireless products include wireless access points and controllers; and compute portfolio including the cisco unified computing system, hyperflex, and software management capabilities, which combine computing, networking, and storage infrastructure management and virtualization. In addition, it provides Internet for the future product consists of routed optical networking, 5G, silicon, and optics solutions; collaboration products, such as meetings, collaboration devices, calling, contact center, and communication platform as a service; end-to-end security product consists of network security, cloud security, security endpoints, unified threat management, and zero trust; and optimized application experiences products including full stack observability and network assurance. Further, the company offers a range of service and support options for its customers, including technical support and advanced services and advisory services. It serves businesses of various sizes, public institutions, governments, and service providers. The company sells its products and services directly, as well as through systems integrators, service providers, other resellers, and distributors. Cisco Systems, Inc. has strategic alliances with other companies. Cisco Systems, Inc. was incorporated in 1984 and is headquartered in San Jose, California.
International Business Machines logo

International Business Machines

NYSE:IBM
International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.
Microsoft logo

Microsoft

NASDAQ:MSFT
Microsoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. This segment also provides LinkedIn; and dynamics business solutions, including Dynamics 365, a set of intelligent, cloud-based applications across ERP, CRM, power apps, and power automate; and on-premises ERP and CRM applications. The Intelligent Cloud segment offers server products and cloud services, such as azure and other cloud services; SQL and windows server, visual studio, system center, and related client access licenses, as well as nuance and GitHub; and enterprise services including enterprise support services, industry solutions, and nuance professional services. The More Personal Computing segment offers Windows, including windows OEM licensing and other non-volume licensing of the Windows operating system; Windows commercial comprising volume licensing of the Windows operating system, windows cloud services, and other Windows commercial offerings; patent licensing; and windows Internet of Things; and devices, such as surface, HoloLens, and PC accessories. Additionally, this segment provides gaming, which includes Xbox hardware and content, and first- and third-party content; Xbox game pass and other subscriptions, cloud gaming, advertising, third-party disc royalties, and other cloud services; and search and news advertising, which includes Bing, Microsoft News and Edge, and third-party affiliates. The company sells its products through OEMs, distributors, and resellers; and directly through digital marketplaces, online, and retail stores. The company was founded in 1975 and is headquartered in Redmond, Washington.
Pfizer logo

Pfizer

NYSE:PFE
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.